BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15341485)

  • 1. A prodrug approach toward the development of water soluble fluoroquinolones and structure--activity relationships of quinoline-3-carboxylic acids.
    Baker WR; Cai S; Dimitroff M; Fang L; Huh KK; Ryckman DR; Shang X; Shawar RM; Therrien JH
    J Med Chem; 2004 Sep; 47(19):4693-709. PubMed ID: 15341485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards calixarene-based prodrugs: Drug release and antibacterial behaviour of a water-soluble nalidixic acid/calix[4]arene ester adduct.
    Dibama HM; Clarot I; Fontanay S; Salem AB; Mourer M; Finance C; Duval RE; Regnouf-de-Vains JB
    Bioorg Med Chem Lett; 2009 May; 19(10):2679-82. PubMed ID: 19395263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Water-soluble phosphate prodrugs of pleuromutilin analogues with potent in vivo antibacterial activity against Gram-positive pathogens.
    Fu L; Jiang Z; Cai Z; Liu X; He H; Yang Y
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5407-10. PubMed ID: 19682897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of water-soluble prodrugs of the HIV-1 protease inhibitor KNI-727: importance of the conversion time for higher gastrointestinal absorption of prodrugs based on spontaneous chemical cleavage.
    Sohma Y; Hayashi Y; Ito T; Matsumoto H; Kimura T; Kiso Y
    J Med Chem; 2003 Sep; 46(19):4124-35. PubMed ID: 12954064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antibacterial activity of new fluoroquinolones containing a substituted N-(phenethyl)piperazine moiety.
    Foroumadi A; Ghodsi S; Emami S; Najjari S; Samadi N; Faramarzi MA; Beikmohammadi L; Shirazi FH; Shafiee A
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3499-503. PubMed ID: 16644219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, in vitro evaluation, and antileishmanial activity of water-soluble prodrugs of buparvaquone.
    Mäntylä A; Garnier T; Rautio J; Nevalainen T; Vepsälainen J; Koskinen A; Croft SL; Järvinen T
    J Med Chem; 2004 Jan; 47(1):188-95. PubMed ID: 14695832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linking bisphosphonates to the free amino groups in fluoroquinolones: preparation of osteotropic prodrugs for the prevention of osteomyelitis.
    Houghton TJ; Tanaka KS; Kang T; Dietrich E; Lafontaine Y; Delorme D; Ferreira SS; Viens F; Arhin FF; Sarmiento I; Lehoux D; Fadhil I; Laquerre K; Liu J; Ostiguy V; Poirier H; Moeck G; Parr TR; Far AR
    J Med Chem; 2008 Nov; 51(21):6955-69. PubMed ID: 18834106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzenesulfonamide analogs of fluoroquinolones. Antibacterial activity and QSAR studies.
    Nieto MJ; Alovero FL; Manzo RH; Mazzieri MR
    Eur J Med Chem; 2005 Apr; 40(4):361-9. PubMed ID: 15804535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and in vitro antibacterial activity of 7-(4-alkoxyimino-3-amino-3-methylpiperidin-1-yl)fluoroquinolone derivatives.
    Chai Y; Wan ZL; Wang B; Guo HY; Liu ML
    Eur J Med Chem; 2009 Oct; 44(10):4063-9. PubMed ID: 19481308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient approach to acyloxymethyl esters of nalidixic acid and in vitro evaluation as intra-ocular prodrugs.
    Azéma J; Guidetti B; Malet-Martino M; Martino R; Roques C
    Bioorg Med Chem; 2006 Apr; 14(8):2569-80. PubMed ID: 16414264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Water-soluble pleuromutilin derivative with excellent in vitro and in vivo antibacterial activity against gram-positive pathogens.
    Hirokawa Y; Kinoshita H; Tanaka T; Nakata K; Kitadai N; Fujimoto K; Kashimoto S; Kojima T; Kato S
    J Med Chem; 2008 Apr; 51(7):1991-4. PubMed ID: 18330977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staphyloferrin A as siderophore-component in fluoroquinolone-based Trojan horse antibiotics.
    Milner SJ; Seve A; Snelling AM; Thomas GH; Kerr KG; Routledge A; Duhme-Klair AK
    Org Biomol Chem; 2013 Jun; 11(21):3461-8. PubMed ID: 23575952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antimycobacterial activity of prodrugs of indeno[2,1-c]quinoline derivatives.
    Upadhayaya RS; Shinde PD; Kadam SA; Bawane AN; Sayyed AY; Kardile RA; Gitay PN; Lahore SV; Dixit SS; Földesi A; Chattopadhyaya J
    Eur J Med Chem; 2011 Apr; 46(4):1306-24. PubMed ID: 21334792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of new series of 1-Aryl-1,4-dihydro-4-oxo-6-methyl pyridazine-3-carboxylic acid as potential antibacterial agents.
    Nagawade RR; Khanna VV; Bhagwat SS; Shinde DB
    Eur J Med Chem; 2005 Dec; 40(12):1325-30. PubMed ID: 16126308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antibacterial activity of novel fluoroquinolones containing substituted piperidines.
    Dang Z; Yang Y; Ji R; Zhang S
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4523-6. PubMed ID: 17566733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The synthesis and biological evaluation of novel series of nitrile-containing fluoroquinolones as antibacterial agents.
    Murphy ST; Case HL; Ellsworth E; Hagen S; Huband M; Joannides T; Limberakis C; Marotti KR; Ottolini AM; Rauckhorst M; Starr J; Stier M; Taylor C; Zhu T; Blaser A; Denny WA; Lu GL; Smaill JB; Rivault F
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2150-5. PubMed ID: 17303420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of human immunodeficiency virus type 1 (HIV-1) attachment 6. Preclinical and human pharmacokinetic profiling of BMS-663749, a phosphonooxymethyl prodrug of the HIV-1 attachment inhibitor 2-(4-benzoyl-1-piperazinyl)-1-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)-2-oxoethanone (BMS-488043).
    Kadow JF; Ueda Y; Meanwell NA; Connolly TP; Wang T; Chen CP; Yeung KS; Zhu J; Bender JA; Yang Z; Parker D; Lin PF; Colonno RJ; Mathew M; Morgan D; Zheng M; Chien C; Grasela D
    J Med Chem; 2012 Mar; 55(5):2048-56. PubMed ID: 22356441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisphosphonated fluoroquinolone esters as osteotropic prodrugs for the prevention of osteomyelitis.
    Tanaka KS; Houghton TJ; Kang T; Dietrich E; Delorme D; Ferreira SS; Caron L; Viens F; Arhin FF; Sarmiento I; Lehoux D; Fadhil I; Laquerre K; Liu J; Ostiguy V; Poirier H; Moeck G; Parr TR; Rafai Far A
    Bioorg Med Chem; 2008 Oct; 16(20):9217-29. PubMed ID: 18815051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nocathiacin analogs: Synthesis and antibacterial activity of novel water-soluble amides.
    Xu L; Farthing AK; Dropinski JF; Meinke PT; McCallum C; Leavitt PS; Hickey EJ; Colwell L; Barrett J; Liu K
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3531-5. PubMed ID: 19447613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological properties of conjugates between fluoroquinolones and a N3''-functionalized pyochelin.
    Noël S; Gasser V; Pesset B; Hoegy F; Rognan D; Schalk IJ; Mislin GL
    Org Biomol Chem; 2011 Dec; 9(24):8288-300. PubMed ID: 22052022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.